BACKGROUND: Harm reduction refers to interventions aimed at reducing the negative effects of health behaviors without necessarily extinguishing the problematic health behaviors completely. The vast majority of the harm reduction literature focuses on the harms of drug use and on specific harm reduction strategies, such as syringe exchange, rather than on the harm reduction philosophy…
Harm Reduction Journal Template
Write in a clean editor, then format for Harm Reduction Journal in one click — DocuGuru applies the official BMC (BioMed Central) template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Harm Reduction Journal format
Harm Reduction Journal is a peer-reviewed journal published by BMC (BioMed Central), covering HIV, Drug Use, Sexual Risk, Opioid Use Disorder Treatment, Substance Abuse Treatment and Outcomes. Over its lifetime it has published 1,816 papers, which have received 43,514 citations.
| Publisher | BMC (BioMed Central) |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. Harm Reduction Journal. 2023;12(3):45–58.
Formats any DOI in Harm Reduction Journal style. No sign-up. |
| Publishes research in | HIV, Drug Use, Sexual Risk Opioid Use Disorder Treatment Substance Abuse Treatment and Outcomes Forensic Toxicology and Drug Analysis HIV/AIDS Research and Interventions |
| ISSN | 1477-7517 |
| Citation impact (2-yr) | 3.75 |
| h-index | 90 |
| i10-index | 987 |
| Article processing charge | $2,440 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | University of British Columbia |
| Journal website | harmreductionjournal.biomedcentral.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Harm Reduction Journal per year
Citation impact of Harm Reduction Journal by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Harm Reduction Journal
BACKGROUND: People who inject drugs (PWID) are a medically and socially vulnerable population with a high incidence of overdose, mental illness, and infections like HIV and hepatitis C. Existing literature describes social and economic correlations to increased health risk, including stigma. Injection drug use stigma has been identified as a major contributor to healthcare disparities…
Children acquire language without instruction as long as they are regularly and meaningfully engaged with an accessible human language. Today, 80% of children born deaf in the developed world are implanted with cochlear devices that allow some of them access to sound in their early years, which helps them to develop speech. However, because of…
Given the current opioid crisis around the world, harm reduction agencies are seeking to help people who use drugs to do so more safely. Many harm reduction agencies are exploring techniques to test illicit drugs to identify and, where possible, quantify their constituents allowing their users to make informed decisions. While these technologies have been…
The impact of COVID-19 across health services, including treatment services for people who use drugs, is emerging but likely to have a high impact. Treatment services for people who use drugs provide essential treatment services including opiate agonist treatment and needle syringe programmes alongside other important treatment programmes across all substance types including withdrawal and…